Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Author(s) -
Chaitra S. Ujjani,
SinHo Jung,
Brandelyn N. Pitcher,
P. G. Martin,
Steven I. Park,
Kristie A. Blum,
Sonali M. Smith,
Myron S. Czuczman,
Matthew S. Davids,
Ellis Levine,
Lionel D. Lewis,
Scott E. Smith,
Nancy L. Bartlett,
John P. Leonard,
Bruce D. Cheson
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mbvm-5959
Subject(s) - lenalidomide , ibrutinib , rituximab , follicular lymphoma , medicine , follicular phase , oncology , lymphoma , chronic lymphocytic leukemia , leukemia , multiple myeloma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom